1. Home
  2. BOSC vs GLTO Comparison

BOSC vs GLTO Comparison

Compare BOSC & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B.O.S. Better Online Solutions

BOSC

B.O.S. Better Online Solutions

HOLD

Current Price

$4.27

Market Cap

26.3M

ML Signal

HOLD

Logo Galecto Inc.

GLTO

Galecto Inc.

HOLD

Current Price

$30.92

Market Cap

23.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOSC
GLTO
Founded
1990
2011
Country
Israel
Denmark
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
23.7M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
BOSC
GLTO
Price
$4.27
$30.92
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
132.7K
207.8K
Earning Date
11-25-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
35.29
N/A
EPS
0.51
N/A
Revenue
$48,333,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.27
N/A
Revenue Growth
19.49
N/A
52 Week Low
$3.14
$2.01
52 Week High
$6.72
$33.60

Technical Indicators

Market Signals
Indicator
BOSC
GLTO
Relative Strength Index (RSI) 37.82 70.94
Support Level $4.36 $25.60
Resistance Level $4.96 $32.20
Average True Range (ATR) 0.26 3.02
MACD -0.02 0.76
Stochastic Oscillator 18.82 92.21

Price Performance

Historical Comparison
BOSC
GLTO

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: